Creative Biolabs-Immuno-oncology

Anti-CD70 (clone VHVL) SynExpress T7-G-I17-B Modified CD8+ T cells (CAT#: ITS-1224-CR1803)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD70 (clone VHVL). We employs the Lentivirus (T7-GFP-IL-17-BamHI) vector components and the SynExpress system of the miRNA Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD70
Clone
VHVL
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.91
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.